Simplex Trading, LLC Cidara Therapeutics, Inc. Transaction History

Simplex Trading, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$0.64 - $0.92 $336 - $483	525 New	525 $0
Q1 2023 Apr 27, 2023	BUY	$0.75 - $1.98 $14,669 - $38,726	19,559 New	19,559 $24,000
Q2 2022 Aug 03, 2022	SELL	$0.43 - $0.91 $273 - $578	-636 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$0.67 - $1.39 $1,614 - $3,349	-2,410 Reduced 79.12%	636 $0
Q4 2021 Feb 23, 2022	BUY	$1.18 - $2.18 $3,594 - $6,640	3,046 New	3,046 $3,000
Q2 2021 Aug 12, 2021	SELL	$1.87 - $2.7 $912 - $1,317	-488 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$2.06 - $3.01 $1,005 - $1,468	488 New	488 $1,000
Q2 2020 Jul 13, 2020	SELL	$2.39 - $4.0 $4,500 - $7,532	-1,883 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$1.74 - $4.26 $3,276 - $8,021	1,883 New	1,883 $4,000
Q4 2019 Feb 05, 2020	SELL	$1.77 - $3.84 $470 - $1,021	-266 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$1.25 - $2.35 $332 - $625	266 New	266 $0
Q2 2018 Jul 30, 2018	SELL	$3.75 - $6.05 $12,078 - $19,487	-3,221 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$4.0 - $8.15 $12,884 - $26,251	3,221 New	3,221 $12,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.24B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.